Clinical studies show that people who take Semaglutide lose about 15 to 17 percent of their body weight over 68 weeks
In the 12 mg group, every participant lost at least 5 percent, 93 percent lost at least 10 percent, and 83 percent lost at least 15 percent
Similarly, early gastrointestinal symptoms - such as a full sensation in the epigastrium, gastric reflux, hypochlorhydria, impaired gastric and intestinal motility, and constipation - are reported by Shimanoza and Katsura in 3050% of patients with TD (70)
The researchers concluded that claims about detoxification, immune enhancement, and disease treatment lack scientific foundation
BMJ 366
The slope of the regression equation derived from this curve represents the time constant, denoted as s